Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
Clinical trial NCT02842125 · TERMINATED
Trial details
- NCT number
- NCT02842125
- Sponsor
- MultiVir, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-05-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.